Pharmaceutical company Galderma has announced that China’s National Medical Products Administration (NPA) has approved Relfydess (relabotulinumtoxinA) for the temporary improvement of moderate-to-severe glabellar lines in adults. The approval is supported
The Royal Society of Medicine’s (RSM) Section of Aesthetic Medicine and Surgery is set to host a multidisciplinary masterclass on
Registration is now live for the Aesthetics Conference & Exhibition (ACE), which will take place on March 12–13, 2027 at
Start free, or unlock the full peer-reviewed journal, CPD and subscriber benefits.
Compare what’s included in each plan.
